SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000060
Filing Date
2021-03-25
Accepted
2021-03-24 19:36:08
Documents
3
Period of Report
2021-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp032421form8k.htm 8-K 31117
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 28765
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 1466
  Complete submission text file 0001607062-21-000060.txt   62531
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 21769624
SIC: 2834 Pharmaceutical Preparations